Pharmanovia
pharmanovia.com
Actively hiring
Prescription Drugs
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
201-500
employees, estimated range
Backers
1
Triton
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Triton Similar startupsby what they do, their industry and backers
Paratek Pharmaceuticals is committed to developing and delivering innovative treatments for serious infectious diseases. Learn about our…
A bold visionfor genetic medicines AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common…
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound…
We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com
Learn how Dispatch Biotherapeutics is expanding the curative potential of immunotherapies by dispatching its Flare platform to overcome…
Learn about how ARTBIO is redefining cancer care through a new class of alpha radioligand therapies and building an ecosystem to maximize…
News
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer - AOL
Read more
Report
IMPACT Therapeutics And Pharmanovia Receive Positive CHMP Opinion For Senaparib As First-Line Maintenance Treatment Of Advanced High-Grade Epithelial Ovarian, Fallopian Tube ...
Read more
Report
LINDIS BIOTECH AND PHARMANOVIA ANNOUNCE EUROPEAN MARKETING AUTHORISATION APPROVAL FOR CATUMAXOMAB, A FIRST-IN-CLASS TREATMENT FOR MALIGNANT ASCITES
ACCESS Newswire Press Release.
Read more
Report
LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
LINDIS Biotech GmbH, a clinical stage biopharmaceutical company with a proprietary multi-specific antibody platform and an advanced development pipeline in immuno-oncology, today announced a licensing agreement with global pharmaceutical company Pharmanov
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
8
Hiring now
0
Countries
6
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Mumbai
India
Regional office
Mumbai, India
Pharmanovia India Private Ltd, Smartworks, Times Square Building, Tower C, 9th Floor, Andheri Kurla Road, Chimatpada. Marol, Andheri, Mumbai
London
United Kingdom
Regional office
London, UK
Atnahs Pharma UK Ltd, 10 Old Bailey, London, EC4M 7NG
Sydney
Australia
Regional office
Sydney, Australia
Atnahs Pharma Australia Pty Ltd, C/o KPMG, Level 38, Tower 3, International Towers Sydney, 300 Barangaroo Avenue, Sydney, NSW 2000, Australia
Copenhagen
Denmark
Regional office
Copenhagen, Demark
Pharmanovia A/S, Copenhagen Towers, Ørestads Boulevard 108, 5.tv, DK-2300 Copenhagen S, Denmark
Vadodara
India
Regional office
Vadodara, India
Pharmanovia India Private Ltd, Building – Vismay 2, Near GIPCL Circle, New Sama Road, New Sama, Vadodara, Gujarat 390008, India
Breda
Netherlands
Regional office
Breda, Netherlands
Pharmanovia Benelux B.V, Burgemeester Guljélaan 2, 4837 CZ Breda, The Netherlands
Fürth
Germany
Regional office
Germany (plus enquiries for DACH region)
Basildon
United Kingdom
Regional office
Sovereign House,
Atnahs Pharma UK Ltd, Sovereign House, Miles Gray Road, Basildon, SS14 3FR, UK